Mohammed Yousuf Karim
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research 24
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 10
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 13
- T-cell and B-cell Immunology 5
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 5
- Hematology top 5%
- Platelet Disorders and Treatments 5
-
- Chronic Lymphocytic Leukemia Research 8
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 5
- Co-authors
- Munther A. KhamashtaJaspal S. KoonerJohn C. ChambersMark B. PepysPaul BassettSimon G. ThompsonJ. Ruth GallimoreDavid D’Cruz
- Cited by
- RheumatologyNephrologyImmunology
- Journals
- Circulation (1 paper)SHILAP Revista de lepidopterología (1 paper)The American Journal of Medicine (1 paper)
- Partner nations
- United KingdomQatarUnited States
In The Last Decade
Mohammed Yousuf Karim
54 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Rheumatology 707
- Nephrology 198
- Immunology 444
- Transplantation 43
- Hematology 159
Countries citing papers authored by Mohammed Yousuf Karim
This map shows the geographic impact of Mohammed Yousuf Karim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Yousuf Karim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Yousuf Karim more than expected).
Fields of papers citing papers by Mohammed Yousuf Karim
This network shows the impact of papers produced by Mohammed Yousuf Karim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Yousuf Karim. The network helps show where Mohammed Yousuf Karim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammed Yousuf Karim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2020 | 3 | |
| 7 | 2020 | 0 | |
| 8 | 2020 | 20 | |
| 9 | 2019 | 19 | |
| 10 | 2017 | 6 | |
| 11 | 2013 | 33 | |
| 12 | 2011 | 42 | |
| 13 | 2010 | 6 | |
| 14 | 2010 | 15 | |
| 15 | 2009 | 47 | |
| 16 | 2005 | 35 | |
| 17 | 2005 | 49 | |
| 18 | 2004 | 46 | |
| 19 | Mycophenolate mofetil: A potential treatment for reducing proteinuria associated with membranous lupus nephritis. | 2003 | 3 |
| 20 | 2003 | 1 |
About Mohammed Yousuf Karim
Mohammed Yousuf Karim is a scholar working on Rheumatology, Transplantation and Nephrology, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (24 papers), Immunodeficiency and Autoimmune Disorders (13 papers), Renal Diseases and Glomerulopathies (10 papers), Chronic Lymphocytic Leukemia Research (8 papers), Renal Transplantation Outcomes and Treatments (5 papers), Platelet Disorders and Treatments (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and T-cell and B-cell Immunology (5 papers). The work is most often cited by research in Rheumatology (707 citations), Nephrology (198 citations) and Immunology (444 citations). Mohammed Yousuf Karim has collaborated with scholars based in United Kingdom, Qatar and United States. Frequent co-authors include Munther A. Khamashta, Jaspal S. Kooner, John C. Chambers, Mark B. Pepys, Paul Bassett, Simon G. Thompson, J. Ruth Gallimore, David D’Cruz, Savino Sciascia and María José Cuadrado. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.